Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP641045.RA6a6Z48g0ZvGkjOTf0_C4wuQn7PiVWrD5_gyJF9HKFpA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP641045.RA6a6Z48g0ZvGkjOTf0_C4wuQn7PiVWrD5_gyJF9HKFpA130_assertion type Assertion NP641045.RA6a6Z48g0ZvGkjOTf0_C4wuQn7PiVWrD5_gyJF9HKFpA130_head.
- NP641045.RA6a6Z48g0ZvGkjOTf0_C4wuQn7PiVWrD5_gyJF9HKFpA130_assertion description "[TRPM2 seems to be a candidate for gene therapy in glioblastoma cells, since the insertion of TRPM2 into A172 cells can facilitate cell death through Ca2+ increase after H2O2 treatment without increasing malignancy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP641045.RA6a6Z48g0ZvGkjOTf0_C4wuQn7PiVWrD5_gyJF9HKFpA130_provenance.
- NP641045.RA6a6Z48g0ZvGkjOTf0_C4wuQn7PiVWrD5_gyJF9HKFpA130_assertion evidence source_evidence_literature NP641045.RA6a6Z48g0ZvGkjOTf0_C4wuQn7PiVWrD5_gyJF9HKFpA130_provenance.
- NP641045.RA6a6Z48g0ZvGkjOTf0_C4wuQn7PiVWrD5_gyJF9HKFpA130_assertion SIO_000772 18225560 NP641045.RA6a6Z48g0ZvGkjOTf0_C4wuQn7PiVWrD5_gyJF9HKFpA130_provenance.
- NP641045.RA6a6Z48g0ZvGkjOTf0_C4wuQn7PiVWrD5_gyJF9HKFpA130_assertion wasDerivedFrom befree-20140225 NP641045.RA6a6Z48g0ZvGkjOTf0_C4wuQn7PiVWrD5_gyJF9HKFpA130_provenance.
- NP641045.RA6a6Z48g0ZvGkjOTf0_C4wuQn7PiVWrD5_gyJF9HKFpA130_assertion wasGeneratedBy ECO_0000203 NP641045.RA6a6Z48g0ZvGkjOTf0_C4wuQn7PiVWrD5_gyJF9HKFpA130_provenance.